Product Name:

CaMK1d-pT180


Product Number:

ab-pk555

Price:

Regular price
$89.00
Regular price
Sale price
$89.00

Download Product PDF

Target Full Name: Calcium/calmodulin-dependent protein-serine kinase 1 delta

Target Alias: CaMK1D; CaMK1-delta; CaM-KI delta; EC 2.7.11.17; KCC1D

Product Type Specific: Protein kinase phosphosite-specific antibody

Antibody Code: PK554

Antibody Target Type: Phosphosite-specific

Antibody Phosphosite: T180

Protein UniProt: Q8IU85

Protein SigNET: Q8IU85

Antibody Type: Polyclonal

Antibody Host Species: Rabbit

Antibody Immunogen Source: Human CaMK1d sequence peptide Cat. No.: PE-04AJA99

Antibody Immunogen Sequence: VMS(pT)ACG(bA)C

Antibody Immunogen Description: Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.

Production Method: Corresponds to amino acid residues V177 to G183; In the protein kinase catalytic domain.

Antibody Modification: Protein kinase phosphosite-specific antibody

Antibody Concentration: 1 mg/ml

Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol

Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.

Product Use: Western blotting | Antibody microarray

Antibody Dilution Recommended: 2 µg/ml for immunoblotting

Antibody Species Reactivity: Human

Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 40-50 kDa.

Antibody Specificity: High

Antibody Cross Reactivity: A weak cross-reactive protein is detected in sorbitol-treated HeLa cells.

Scientific Background: CaMK1d is a protein-serine/threonine kinase of the CaMK group and CaMK1 family. It is activated by Ca2+/calmodulin. The binding of calmodulin is thought to result in a conformational change and can lead to subsequent activation through phosphorylation by CaMKK1 and CaMKK2. At least in part, it can also be activated by CaMKK1 in a calcium-independent manner. It is associated with calcium-triggered CaMKK-CaMK1 signalling cascade and activates CREB- and CREM-BETA-dependent gene transcription. A K52A mutation leads to a loss of phosphotransferase function.